The ruling shows Novo Nordisk’s confidence that the supply of semaglutide will be stable for now.
The shortage of semaglutide injections (Ozempic, Wegovy) is over, the FDA announced on Friday. The agency, along with maker ...
Feb. 21, the Food and Drug Administration said there is no longer a short supply of the weight loss and diabetes drugs Wegovy ...
American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...